MC

473.05

+0.17%↑

SANES

10.296

+0.88%↑

SAF

273.4

+1.15%↑

BBVA

18.705

+0.97%↑

BNP

90.29

+1.5%↑

MC

473.05

+0.17%↑

SANES

10.296

+0.88%↑

SAF

273.4

+1.15%↑

BBVA

18.705

+0.97%↑

BNP

90.29

+1.5%↑

MC

473.05

+0.17%↑

SANES

10.296

+0.88%↑

SAF

273.4

+1.15%↑

BBVA

18.705

+0.97%↑

BNP

90.29

+1.5%↑

MC

473.05

+0.17%↑

SANES

10.296

+0.88%↑

SAF

273.4

+1.15%↑

BBVA

18.705

+0.97%↑

BNP

90.29

+1.5%↑

MC

473.05

+0.17%↑

SANES

10.296

+0.88%↑

SAF

273.4

+1.15%↑

BBVA

18.705

+0.97%↑

BNP

90.29

+1.5%↑

Search

Gimv NV

Atvērts

SektorsFinanšu

47.55 0.32

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

47.25

Max

47.55

Galvenie mērījumi

By Trading Economics

Ienākumi

127M

Pārdošana

65M

P/E

Sektora vidējais

8.282

39.62

EPS

3.4

Dividenžu ienesīgums

5.27

Peļņas marža

195.239

Darbinieki

94

EBITDA

128M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.27%

4.52%

Nākamie ieņēmumi

2026. g. 21. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.8B

Iepriekšējā atvēršanas cena

47.23

Iepriekšējā slēgšanas cena

47.55

Ziņu noskaņojums

By Acuity

50%

50%

191 / 439 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 26. apr. 21:14 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

2026. g. 26. apr. 21:14 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: Major Central Bank -2-

2026. g. 24. apr. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Group Rejects EQT's Revised Offer

2026. g. 26. apr. 23:48 UTC

Tirgus saruna

Nikkei May Rise After U.S. Tech Gains -- Market Talk

2026. g. 26. apr. 23:44 UTC

Peļņas

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

2026. g. 26. apr. 23:44 UTC

Peļņas

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

2026. g. 26. apr. 23:36 UTC

Tirgus saruna
Galvenie ziņu notikumi

Gold Falls Amid Dollar's Strength -- Market Talk

2026. g. 26. apr. 23:33 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

2026. g. 26. apr. 05:12 UTC

Peļņas

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

2026. g. 24. apr. 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Scoring the Cook Era -- Barrons.com

2026. g. 24. apr. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 24. apr. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:09 UTC

Peļņas

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026. g. 24. apr. 19:48 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026. g. 24. apr. 19:22 UTC

Peļņas

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026. g. 24. apr. 19:06 UTC

Peļņas

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026. g. 24. apr. 19:05 UTC

Tirgus saruna

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026. g. 24. apr. 18:30 UTC

Iegādes, apvienošanās, pārņemšana

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026. g. 24. apr. 18:28 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Rejects Revised EQT Offer

2026. g. 24. apr. 18:12 UTC

Tirgus saruna

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026. g. 24. apr. 18:06 UTC

Tirgus saruna

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026. g. 24. apr. 17:42 UTC

Peļņas

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Peļņas

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

191 / 439 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat